ALX ONCOLOGY HOLDINGS INC Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2026-03-09
- ALX ONCOLOGY HOLDINGS INC unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2025 was $0.00.
- ALX ONCOLOGY HOLDINGS INC unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2024 was $0.00.
- ALX ONCOLOGY HOLDINGS INC unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2023 was $0.00.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-09 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-09 |
| 2023-12-31 | $0.00 10-K · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |